Article
BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications.
The American journal of pathology - 1 May 2000
Goggins M, Hruban R H, Kern S E
Abstract excerpt
Patients harboring germline BRCA2 mutations are at an increased risk of developing pancreatic cancer. We investigated the prevalence of biallelic inactivation of BRCA2 in the presumed precursors to invasive pancreatic ductal carcinomas, pancreatic intraepithelial neoplasia (PanIN). Surgical resec...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
